QUOTED. Kevin Sayer.
Executive Summary
In an interview with Medtech Insight following the J.P. Morgan Health Care Conference, Dexcom CEO Kevin Sayer discussed marketing plans for the next-generation G7 continuous glucose monitoring system and for the simpler CGM, Dexcom One, and outlined plans ahead.
"We will focus our US rollout on our larger markets, and, in particular, on markets where we have a direct presence and larger markets where CGM is more reimbursed, because we want to get to as many people as fast as we can." - Kevin Sayer, CEO, Dexcom
- Find out more: Exec Chat: Dexcom’s CEO Bullish On Year Ahead With G7 CGM Launch, Dexcom One CGM Expansion
Click here for a free trial of Medtech Insight